Viewing Study NCT05113368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2026-02-01 @ 2:43 PM
Study NCT ID: NCT05113368
Status: RECRUITING
Last Update Posted: 2025-08-21
First Post: 2021-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Sponsor: Sarah K. Lynam MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Serous Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian Cancer View
None serous ovarian cancer View
None Fulvestrant View
None Regorafenib View